By Administrator at 10 Sep 2020
Precision oncology aims for cures that are more effective and less toxic than conventional therapies by targeting the biological pathways that drive certain cancers. This growing field has long been a focus of Gateway for Cancer Research. Earlier this year, Gateway and Conquer Cancer®, the ASCO Foundation presented the annual Young Investigators Award to Laura Agresta, MD, to advance her precision oncology trial to treat pediatric acute myeloid leukemia.
Current Gateway-funded clinical trials
Clinical trials funded at leading institutions worldwide
Funds one patient for one day at a Gateway-funded clinical trial